Company intelligence / Profile preview

Chongqing Fujin Biopharmaceutical

Chongqing, Chongqing, Chinaxsbiopharm.com ↗

Ownership: Private
Development stage: Other

Overview

Chongqing Fujin Biological Medicine is an active Chinese biopharmaceutical company specializing in the research, development, manufacture, and commercialization of innovative biological drugs—primarily focused on metabolic/endocrine disorders such as diabetes with advanced insulins—and infectious diseases like hepatitis C with peg-interferons. The company’s lead products include approved therapies within China as well as several pending or late-stage candidates across multiple indications related to endocrinology/metabolism and infectious disease.

Therapeutic areas: NeurologyInfectious DiseasesHematologyEndocrinologyRheumatology
Modalities: Recombinant proteinPegylated recombinant proteinBiosimilarSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Chongqing Fujin Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Fujin Biopharmaceutical.

Explore the full profile